Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-Dog CD20/MS4A1 Antibody (Iv0177)

Catalog #:   VQC90702 Specific References (50) DATASHEET
Host species: Dog
Isotype: IgG2, kappa
Applications: ELISA, Neutralization
Accession: Q3C2E2
Overview

Catalog No.

VQC90702

Species reactivity

Dog

Host species

Dog

Isotype

IgG2, kappa

Clonality

Monoclonal

Target

B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q3C2E2

Applications

ELISA, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Iv0177

Data Image
References

Pathological Study on Trigeminal Ganglionitis Among Rabid Dogs in the Philippines., PMID:40284801

Case report: Clinical and immunohistochemical manifestations of suspected Sjogren's disease in a dog., PMID:39711802

Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma., PMID:38662527

Melan-A immunolabeling in canine extramedullary plasmacytomas., PMID:38642035

Multiple myeloma in dogs: Use of the cell block technique as a new diagnostic tool., PMID:38240087

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma., PMID:37624862

Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99., PMID:37298173

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models., PMID:37223101

Co-Expression of T- and B-Cell Markers in a Canine Intestinal Lymphoma: A Case Report., PMID:36552451

Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma., PMID:36551672

Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients., PMID:35878344

Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy., PMID:35177658

Gastric Plasmacytoma with Immunoglobulin Lambda Light Chain Deposition in a Dog., PMID:34503657

Development of a cell line-based assay to measure the antibody-dependent cellular cytotoxicity of a canine therapeutic antibody., PMID:34450340

Immunohistochemical Characterization of Tumor-Associated Macrophages in Canine Lymphomas., PMID:34438760

Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells., PMID:34408098

A rapid multiple immunofluorescence method for the simultaneous detection of CD20 and CD3 in canine and feline cytological samples., PMID:33814519

Nonhypoalbuminemic Inflammatory Bowel Disease in Dogs as Disease Model., PMID:33783501

Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody., PMID:33284343

CD3-CD20-positive nodal lymphoma with cross-lineage rearrangement in a dog., PMID:33000710

Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia., PMID:32814628

Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment., PMID:32651429

Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma., PMID:32002286

Targeting CD20: teaching an old dog new tricks., PMID:31808844

Diagnostic immunohistochemistry for canine cutaneous round cell tumours - retrospective analysis of 60 cases., PMID:31553052

Clinicopathologic Features, Diagnosis, and Characterization of the Immune Cell Population in Canine Choroid Plexus Tumors., PMID:31380398

Optimized immunocytochemistry using leukocyte and tissue markers on Romanowsky-stained slides from dogs and cats., PMID:31347181

Prevalence of CD20+ cutaneous epitheliotropic T-cell lymphoma in dogs: a retrospective analysis of 24 cases (2011-2018) in the USA., PMID:30474245

CD3 and CD20 co-expression in a case of canine peripheral T-cell lymphoma with prominent cardiac and peripheral nerve involvement., PMID:30129396

Pathological features of intestinal T-cell lymphoma in Shiba dogs in Japan., PMID:29575510

Histological and Immunological Description of the Leishmanin Skin Test in Ibizan Hounds., PMID:29422316

Effects of Electrochemotherapy with Cisplatin and Peritumoral IL-12 Gene Electrotransfer on Canine Mast Cell Tumors: a Histopathologic and Immunohistochemical Study., PMID:28959165

A retrospective study comparing histopathological and immunopathological features of nasal planum dermatitis in 20 dogs with discoid lupus erythematosus or leishmaniosis., PMID:28133824

Therapies: Progressive steps., PMID:27902682

Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20., PMID:27856424

The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine., PMID:26894679

Cancer immunotherapy in veterinary medicine: Current options and new developments., PMID:26545847

CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides)., PMID:26354309

Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera., PMID:26133610

Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma., PMID:25764941

A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo., PMID:25517311

Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential., PMID:24724777

Comprehensive immunohistochemical studies on canine necrotizing meningoencephalitis (NME), necrotizing leukoencephalitis (NLE), and granulomatous meningoencephalomyelitis (GME)., PMID:22262353

Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20., PMID:18039900

Cross-reactive anti-human monoclonal antibodies as a tool for B-cell identification in dogs and pigs., PMID:17673300

The role of rituximab in the treatment of canine lymphoma: an ex vivo evaluation., PMID:16624725

Canine CD20 gene., PMID:16061290

CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma., PMID:16006606

Evaluation of the cross-reactivity between human and feline or canine leucocyte antigens using commercially available antibodies., PMID:9087936

Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood., PMID:2137673

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-Dog CD20/MS4A1 Antibody (Iv0177) [VQC90702]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only